Heart failure

Where the papers sit

10 papers from the last 6 months study heart failure directly · updated from PubMed 10 Oct 2026

• Heart Failure Epidemiology and Biomarkers

  Heart failure work is defining population burden and associated clinical risks in routine care. Type 2 diabetes marks higher hospitalization risk and substantial healthcare utilization, while prevalence remains important in high-cardiovascular-risk patients. Iron deficiency is being characterized in primary care, and trimethyllysine is being explored as a biomarker. The shared direction is better risk stratification and comorbidity recognition, not a demonstrated therapeutic shift.

  4 papers · 40%

• Cardiovascular Outcomes and Care

  Cardiovascular outcomes are being studied through improved event ascertainment, social context, risk linkage, and home-based care. Electronic medical record retrieval and large language models target more reliable identification of cardiovascular events. Other work connects neighborhood mortgage bias or atrial fibrillation with stroke and major adverse cardiovascular events, while telemonitoring examines home nursing implementation. The common direction is broader, more context-aware cardiovascular surveillance and care delivery.

  4 papers · 40%

• Others — MPO Inhibition and Airway Microbiomes

  Molecular drug development and airway ecology occupy separate lines here. Mitiperstat work centers on population pharmacokinetics of myeloperoxidase inhibition, whereas respiratory microbiome work follows dysbiosis, mucociliary clearance, bronchiectasis, and infection. No shared clinical endpoint or mechanism links the two. The cluster therefore does not support a single direction.

  2 papers · 20%